Civitarese [12] et al. have revealed that ADIPOR1 and ADIPOR2 isoforms may be important therapeutic targets for improving insulin sensitivity in patients with T2DM or in individuals at risk of developing the disease. This evidence concerns the gene INS and type 2 diabetes mellitus.